Innoviva (INVA) Net Margin (QoQ) (2011 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Innoviva | 1.60 Bn | 992.84 Mn | 75.83 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 146,439.00 |
| Dec 31, 2025 | -135,742.00 |
| Sep 30, 2025 | 1,990.00 |
| Jun 30, 2025 | 11,607.00 |
| Mar 31, 2025 | 80,080.00 |
| Dec 31, 2024 | -85,472.00 |
| Sep 30, 2024 | 3,608.00 |
| Jun 30, 2024 | -381,567.00 |
| Mar 31, 2024 | 421,145.00 |
| Dec 31, 2023 | -55,248.00 |
| Sep 30, 2023 | -863.00 |
| Jun 30, 2023 | -424,941.00 |
| Mar 31, 2023 | 536,271.00 |
| Dec 31, 2022 | -2.14 Mn |
| Sep 30, 2022 | 2.04 Mn |
| Jun 30, 2022 | -122,627.00 |
| Mar 31, 2022 | 188,766.00 |
| Dec 31, 2021 | -68,555.00 |
| Sep 30, 2021 | -754,139.00 |
| Jun 30, 2021 | -121,414.00 |
| Mar 31, 2021 | -186,549.00 |
| Dec 31, 2020 | 1.07 Mn |
| Sep 30, 2020 | -6,552.00 |
| Jun 30, 2020 | 1,417.00 |
| Mar 31, 2020 | 2,269.00 |
| Dec 31, 2019 | -6.00 |
| Sep 30, 2019 | 167.00 |
| Jun 30, 2019 | -236.00 |
| Mar 31, 2019 | -26,905.00 |
| Dec 31, 2018 | 25,394.00 |
| Sep 30, 2018 | -508.00 |
| Jun 30, 2018 | 2,495.00 |
| Mar 31, 2018 | -2,751.00 |
| Dec 31, 2017 | 3,512.00 |
| Sep 30, 2017 | -1,115.00 |
| Jun 30, 2017 | 1,841.00 |
| Mar 31, 2017 | -1,775.00 |
| Dec 31, 2016 | 1,422.00 |
| Sep 30, 2016 | 18.00 |
| Jun 30, 2016 | 2,661.00 |
| Mar 31, 2016 | -49.00 |
| Dec 31, 2015 | 5,263.00 |
| Sep 30, 2015 | 3,950.00 |
| Jun 30, 2015 | 8,138.00 |
| Mar 31, 2015 | 6,408.00 |
| Dec 31, 2014 | 191,047.00 |
| Sep 30, 2014 | 467,634.00 |
| Jun 30, 2014 | 187,430.00 |
| Mar 31, 2014 | -529,026.00 |
| Dec 31, 2013 | 793,207.00 |
| Sep 30, 2013 | -856,609.00 |
| Jun 30, 2013 | 7,042.00 |
| Mar 31, 2013 | -285,121.00 |
| Dec 31, 2012 | 245,120.00 |
| Sep 30, 2012 | 467,150.00 |
| Jun 30, 2012 | -716,476.00 |
| Mar 31, 2012 | 75,742.00 |
| Dec 31, 2011 | -21,395.00 |
| Sep 30, 2011 | -8,422.00 |
| Jun 30, 2011 | -3,397.00 |